Showing results (101-110 of 291) with videos related to
Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry Letters|June 2, 2012
New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramidesPeter J Jervis, Lisa M Graham, Erin L Foster, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1cD H Geho, J D Fayen, R M Jackman, et al.Infection and Immunity|September 29, 2020
Identification of Autophagy-Inhibiting Factors of Mycobacterium tuberculosis by High-Throughput Loss-of-Function ScreeningEmily J Strong, Kristen L Jurcic Smith, Neeraj K Saini, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1cP A Sieling, S A Porcelli, B T Duong, et al.Clinical and Experimental Immunology|March 3, 2011
Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetesR Tohn, H Blumenfeld, S M M Haeryfar, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cellsT Takahashi, M Nieda, Y Koezuka, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunityP A Sieling, D Jullien, M Dahlem, et al.Journal of Endocrinological Investigation|February 24, 2007
Large idiopathic unilateral adrenal hematoma in a young womanL A Marzano, L Tauchmanova, E Marzano, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigensKenji Hiromatsu, Christopher C Dascher, Kenneth P LeClair, et al.Clinical and Experimental Immunology|December 18, 2009
An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetesD Ly, R Tohn, B Rubin, et al.Pageof 30